Versant Venture Management, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 12, 2026, Versant Venture Management, Llc disclosed 8 stock positions valued at approximately $162.61M as of quarter-end June 30, 2026. The largest holdings include Monte Rosa Therapeutics, Inc., Century Therapeutics, Inc., and Jade Biosciences, Inc..
- Report Period
- June 30, 2026
- No. of Stocks
- 8
- Portfolio Value
- $162.61M
Holdings by Sector
Versant Venture Management, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | GLUE | Healthcare | 47.34% | 3,180,780 | - | - | $76,974,876 |
| Century Therapeutics, Inc. | IPSC | Healthcare | 18.33% | 12,166,109 | - | - | $29,806,967 |
| Jade Biosciences, Inc. | JBIO | Other | 13.55% | 991,783 | -534,037 | -35.00% | $22,037,418 |
| Lenz Therapeutics, Inc. | LENZ | Healthcare | 9.28% | 2,656,888 | - | - | $15,091,124 |
| Contineum Therapeutics, Inc. | CTNM | Healthcare | 5.47% | 542,628 | - | - | $8,893,673 |
| CRISPR Therapeutics AG | CRSP | Other | 4.99% | 148,831 | - | - | $8,117,243 |
| Skye Bioscience, Inc. | SKYE | Healthcare | 0.86% | 2,007,704 | - | - | $1,391,941 |
| Tempest Therapeutics, Inc. | TPST | Healthcare | 0.18% | 269,772 | - | - | $299,447 |
Showing 8 of 8 holdings in the latest reporting period.